An immunoreactive, structural, and functional analog of erythrocyte protein 4.1 is present in neuronal cell bodies and dendrite.s.
Other investigators have described the isolation of a 4.1 analog in brain with structural characteristics suggesting that its identity was synapsin I, a neuronal phosphoprotein localized in the presynaptic terminal in association with small synaptic vesicles.
In this report we demonstrate that the cell body/dendriticform of brain protein 4.1, which we have named amelin, is distinct from that of synapsin I on the basis of subcellular localization, migration in 2-dimensional gel electrophoresis, and structural criteria. We also demonstrate that amelin, like synapsin I, can bind brain spectrin on nitrocellulose paper. Neither amelin nor synapsin I binds calmodulin, as determined by a blot binding assay. We hypothesize that there exists in brain a family of 4.1 -related proteins with distinct subcellular localization and function.
An analog of erythrocyte protein 4.1 has been identified in the cell bodies and dendrites of neurons, as well as in the cell bodies of certain glial cells (Goodman et al., 1984a) . On the basis of immunoblotting of pig brain proteins separated by SDS-PAGE (in a continuous buffer system; Fairbanks et al., 197 1) with an antibody against pig red blood cell (rbc) protein 4.1, the brain protein 4.1 was assigned an apparent molecular weight of 87 kDa. Tryptic peptide mapping of this brain protein 4.1 analog versus that of rbc protein 4.1 indicated partial structural homology (Goodman et al., 1984a) . These findings were significant because rbc protein 4.1 serves to stimulate the binding of rbc spectrin to actin, as well as to link the cytoskeleton and the membrane bilayer (see review by Goodman et al., 1984b) .
Therefore it was possible that brain protein 4.1 might serve a similar function in the neuron. Subsequent work by others (Baines and Bennett, 1985) indicated that a brain protein that was identified as an analog of rbc protein 4.1 appeared to be identical to the neuronal phosphoprotein designated synapsin I (DeCamilli et al., 1983) . This brain protein 4.1 analog and synapsin I both consisted of a doublet of polypeptides of -75 and 73 kDa on SDS-PAGE in gard, 1983 for a review). However, this finding raised the question of whether synapsin I was equivalent to the brain protein 4.1 analog originally described (Goodman et al., 1984a) or, alternatively, whether there were 2 distinct brain protein 4.1 analogs. The fact that synapsin I has been reported to be localized exclusively on the cytoplasmic surface of synaptic vesicles in the presynaptic terminals of neurons (DeCamilli et al., 1983) has suggested that the latter possibility might be correct. In this report we demonstrate that the brain protein 4.1 analog described by Goodman and colleagues (1984a) , which we have named amelin (from the Greek amelew, to overlook), is structurally and immunologically distinct from synapsin I, and we have confirmed the fact that these 2 brain protein 4.1 analogs have different locations within neurons. These studies have been presented in preliminary form .
Materials and Methods
Protein purification Mouse brain total protein. Mice (C57 BW6J) were anesthetized with ether and perfused through the heart with PBS (5 mM NaPO,, pH 7.4, 155 mM NaCl) until the perfusate was clear. The brains were immediately removed and frozen in liquid nitrogen. Five brains (2 pm) were homogenized at 2000 rpm with a Teflon homogenizer in 50 ml of chloroform/methanol (2: 1, vol/vol) containing 0.25 mM phenylmethylsulfonyl fluoride, and the filtrate was prepared by the priced&e of Chou et al. (1976) . The protein precipitate was redissolved in 10 ml of nonequilibrium pH gradient gel electrophoresis (NEPHGE) sample buffer (9 M urea, 2% Triton X-100, 5% P-mercaptoethanol, and 0.8% ampholine), as described by O'Farrell et al. (1977) , and frozen in 500 pl aliquots at -70°C for later use. Mouse brain spectrin. Forty mice were perfused as described above. Brain spectrin was isolated as described (Goodman et al., 1983) . Previous studies have demonstrated that spectrin isolated by this protocol yields a mixture of brain spectrin(240/235) and brain spectrin(240/ 235E) . SDS-PAGE revealed an essentially pure preparation of spectrin. The mouse brain spectrin was iodinated by the method of Bolton and Hunter (1973) as described, and was dialyzed against 2 changes of assay buffer [80 mM KCl, 20 mM NaCl, 5 mM NaPO,, pH 7.4, 1 mM EGTA, 0.25 mM dithiothreitol (DTT)]. The lZ51-brain spectrin had a specific activity of 26 rCi/mg.
Calmodulin. Calmodulin was purified from bovine brain using mellitin-Sepharose affinity chromatography (Kincaid and Coulson, 1985) .
Calmodulin was biotinylated in the presence of Ca2+ by reaction using biotinylepsilon-amino-caproic acid N-hydroxysuccinamide ester as described (Billingsley et al., 1985) .
Results
Antibody production. Pig etythrocyte protein 4.1 was purified to homogeneity by the published procedure (Tyler et al., 1980) for use as an immunogen. Pure bovine dephospho-synapsin I was produced by our published procedure (Krebs et al., 1986a) . Antibodies were produced as described (Krebs et al., 1986a) . The pig erythrocyte 4.1 antiserum cross-reacted exclusively with erythrocyte 4.1 at 1:300 dilution (Goodman et al., 1984a) , and the synapsin I antisera cross-reacted exclusively with the synapsin I doublet at a 1: 1000 dilution (Krebs et al., 1986a) .
Immunohistochemistry. A mouse was perfused, the cerebellum immediately frozen in Freon-12, and cryostat sections (10 pm) prepared for indirect immunofluorescent studies using rhodamine-conjugated goat anti-rabbit InG (Caopel Laboratories) as previouslv described (Goodman et al., i984a) . *Cryostat sections' were incubated with pig rbc 4.1 antisera or bovine synapsin I antisera at 150 dilution in PBS containing 2% normal goat serum (NGS). Controls were performed using preimmune rabbit serum adjusted to give an IgG concentration identical to that of the rbc 4.1 antiserum. The sections were mounted and photographed with an Olympus fluorescence microscope.
Electrophoresis and protein transfer. The total brain protein filtrate (150 J) was loaded onto 1.5 x lo.5 cm NEPHGE (pH 8-10.5 or 6-10.5) tube aels. as described bv O'Farrell et al. (1977) . The nroteins were electrgphoresed at 400 V-constant voltage fbr 4 hr, and-the gels were electrophoresed in the second dimension in a 7% polyacrylamide gel using the Laemmli discontinuous buffer system (Laemmli, 1970) . The gels were stained with Coomassie blue, or electrophoretically transferred as described (Towbin et al., 1979) to nitrocellulose (Millipore, 0.45 km). Blots were either stained with amido black, reacted with antisera, or overlayed with 1251-spectrin or biotinylated calmodulin.
ImmunoblottinK. Duplicate electrophoretic transfers of the NEPHGE pH 8-10.5 gel were incubated with pig rbc 4.1 antisera (1:300 dilution) or bovine svnansin I antisera (1: 1000 dilution) in TBSB 110 mM Tris, pH 7.4, 155-m; NaCl, 5% non-fat dried milk (Carnation), &OS% Tween-201 for 12 hr. The transfers were incubated for 3 hr at 25°C with TBSB containing Y-protein A (sp act, 80 cpm/pl). The transfers were autoradiographed (Kodak X-Omat XAR-5 film) with a DuPont Cronex Lightning Plus intensifying screen for 2 d (rbc 4.1 antisera) or 12 hr (synapsin I antisera) at -20°C.
125Z-Brain spectrin overlay. Duplicate electrophoretic transfers of the NEPHGE pH 6-10.5 gel were incubated with 1Z51-mouse brain spectrin (10 nM) or 1251-heat-denatured (90°C for 15 min) brain spectrin for 3 hr at 25°C with constant shaking in assay buffer (80 mM KCl, 20 mM NaCl, 5 mM NaPO,, pH 7.4, 1 mM EGTA, 0.25 mM DTT, 5% non-fat dried milk, 0.05% Tween-20). The transfers were autoradiographed with an intensifying screen for 66 hr at -20°C.
Biotinylated calmodulin overlay. Nitrocellulose electroblots obtained from NEPHGE 2-dimensional gels were incubated in TBSB for 12 hr at 4°C washed 3 times in TBSBcontaining 1 mM CaZ+, and incubated with biotinylated calmodulin (25 pg in 10 ml TBSB/I mM Ca*+) for 30 min at 25°C. Blots were then washed 3 times in TBSB/l mM CaZ+. and bound biotinylated calmodulin was detected using avidin-alkaline phosphatase complexes (BioMeda Labs) dissolved in TBSB/l mM Ca*+. After a 30 min incubation, blots were washed 3 times in TBSB/l mM Ca2+, which was followed by chromogenic development using nitroblue tetrazolium chloride (200 ~1 at 50 mg/ml in 50% dimethylformamide; Amresco) and 5-bromo-4-chloro-3-indoyl phosphate p-toluidine salt (100 ul at 50 me/ml in 100% dimethvlformamide): both dissolved in 30 ml of 0.1 ~Tris-HCl, pH 9.5, 100 mM NaCl, 50 mM MgCl,. One lane of the second-dimension NEPHGE gel was loaded with a mixture of bovine brain calcineurin, caldesmon, and spectrin as positive controls for biotinylated calmodulin binding; the proteins were prepared from bovine brain using calmodulin affinity chromatography (Billingsley et al., 1985) .
Iodopeptide maps. The Coomassie blue-stained bands corresponding to mouse amelin and mouse synapsin Ib from 2-dimensional gel electrophoresis, and the Coomassie blue-stained band corresponding to mouse erythrocyte 4.1 b from mouse erythrocyte ghosts, electrophoresed in a 7% polyacrylamide gel with discontinuous buffer system, were excised and iodinated in the gel slices with 1251-NaI (Amersham) as described (Elder et al., 1977) . The iodinated proteins were digested with ol-chymottypsin and the digests were electrophoresed and chromatographed as described (Goodman et al., 1982) .
Protein determination. Protein concentrations were determined by a modification of the method of Bradford (1976) using bovine serum albumin as a standard.
Immunohistochemical localization of amelin and synapsin I
Immunohistochemical analysis was performed on 10 pm cryostat sections of mouse cerebellum stained with a rabbit antibody against pig rbc 4.1 (Goodman et al., 1984a) or bovine synapsin I, followed by rhodamine-conjugated goat anti-rabbit IgG. The pig rbc 4.1 antibody is the identical antibody used and characterized in the original description of brain protein 4.1 (Goodman et al., 1984a) , and the synapsin I antibody stains the synapsin Ia and Ib doublet exclusively (Krebs et al., 1986a) . The comparative, low-magnification overview of the cerebellum stained with anti-rbc 4.1 (Fig. 1A) or anti-synapsin I (Fig. 1D ) clearly indicated that these antibodies were detecting different antigens. The rbc 4.1 antibody moderately stained the internal granule layer, but only weakly stained the molecular and medullary layers (Fig. 1A) . A higher-magnification view of the internal granule layer (Fig. 1B) indicated that the thin rim of cell body cytoplasm of each granule cell neuron was being stained by the rbc 4.1 antibody.
Purkinje cell bodies were also stained ( Fig. lA) , as were their dendrites (not shown). Axons were not stained by the rbc 4.1 antibody.
Alternatively, the synapsin I antibody intensely stained the molecular layer, moderately stained the internal granule layer, and weakly stained the medullary layer (Fig. 1D) . The bright staining of the molecular layer (Fig. lD) , and the bright staining of glomeruli between granule cells (Fig. IE) , is consistent with the localization of synapsin I in presynaptic terminals, as described by Greengard and colleagues (DeCamilli et al., 1983) . We have not observed staining of neuronal cell bodies, dendrites, or axons with this synapsin I antibody.
Sections incubated with preimmune serum demonstrated negligible staining of the internal granule layer (Fig.  1 C) or the molecular layer ofthe cerebellum (Fig. 1F) . Therefore, while the rbc 4.1 antibody was recognizing an antigen present in neuronal cell bodies and dendrites (as well as certain glial cells; Goodman et al., 1984a) , the synapsin I antibody specifically stained synaptic terminals.
Separation of amelin and synapsin I in 2-dimensional NEPHGE/NaDodSObPAGE gels
The antibody against rbc protein 4.1 that was used in this study has previously been demonstrated to specifically cross-react with a single polypeptide with an apparent molecular weight of 87 kDa when total brain homogenate protein was separated by l-dimensional SDS-PAGE in a continuous buffer system (Goodman et al., 1984a) . As we have previously demonstrated that this rbc 4.1 antibody cross-reacts with a single brain protein of 87 kDa A4, in this continuous buffer system (Fairbanks et al., 197 l) , and that synapsin I also migrates as a single broad band of -87 kDa in this gel system , we wanted to determine whether synapsin I was the protein being detected. We therefore chose to use the higher-resolution technique of 2-dimensional gel electrophoresis, consisting of NEPHGE in the first dimension, followed by second-dimension SDS-PAGE in a discontinuous buffer system. As shown in Figure 2 , when mouse brain extract was subjected to NEPHGE/ SDS-PAGE, amelin (as recognized by anti-rbc protein 4.1) migrated as a basic protein (ran to a pH of 8.5) with an apparent molecular weight of -93 kDa (Fig. 2, A, c) . In contrast, synapsin I (as recognized by anti-synapsin I) was a more basic protein than amelin (synapsin I migrated to a pH of 10.3), which split into a doublet of 76 and 70 kDa (Fig. 2, A, B) . This 2-dimen-sional gel system demonstrates that amelin (the protein recognized by this rbc 4.1 antibody) differs from synapsin I in both isoelectric point and apparent molecular weight.
Amelin is a spectrin-binding protein It had previously been shown that synapsin I is capable of binding Y-brain spectrin by a blot binding assay (Baines and Bennett, 1985) . Using a similar blot binding assay, both amelin and synapsin I, separated by the NEPHGE 2-dimensional gel system, bound lZSI-brain spectrin (Fig. 3c) , which was isolated by a protocol (Goodman et al., 1983 ) that yields a mixture of brain spectrin(240/235) and brain spectrin(240/235E) . In addition to amelin and synapsin I, 3 proteins of 178, 159, and 124 kDa apparent M, bound 1251-spectrin. Lower-molecular-weight spots of 40-20 kDa, which correspond to known synapsin I breakdown products (as determined by cross-reactivity with antisera against synapsin I), also bound lZ51-brain spectrin. The possibility that the binding of '251-brain spectrin to proteins adsorbed to nitrocellulose paper may represent nonspecific binding to basic proteins appears unlikely for several reasons.
(1) Of the -7 1 protein spots observed on the amido black-stained blot of the brain homogenate protein separated by the NEPHGE 2-dimensional gel system (Fig. 3A) , only 11 are capable of binding spectrin ( Fig. 3C') ; 7 of the 11 spectrinbinding proteins have already been identified as amelin, synapsin Ia, synapsin Ib, and synapsin I proteolytic fragments. (2) The proteins on the blot that most efficiently bind brain spectrin are a doublet of neutral proteins (which ran to a pH of 7.5) that can barely be detected on the amido black-stained blot (Fig.  3A) , but are clearly stained on the 1251-brain spectrin blot (arrowhead in Fig. 3C ). (3) Although synapsin Ia and Ib are sequence-related, extremely basic proteins with nearly identical isoelectric points, synapsin Ia binds 1251-brain spectrin strongly, while the binding to synapsin Ib is very weak (Fig. 3C ). This result cannot be reconciled with the conclusion that binding of 1251-brain spectrin to proteins attached to nitrocellulose paper is nonspecific. (4) The proteins in the blot in Figure 3C did not bind the heat-denatured 1251-brain spectrin (Fig. 30) . Heat denaturation of spectrin has typically been used as a specificity control for spectrin interactions. Under the conditions used (90°C 15 min), only 11% of the brain spectrin becomes precipitable (sediments at 40,000 x g, 30 min). Therefore, we believe that heat denaturation is a better control than competition with high concentrations of brain spectrin (1 mg/ml), where the majority of spectrin becomes precipitable. The '251-spectrin-blotting experiment indicates that amelin attached to nitrocellulose paper has the capacity to bind spectrin. When amelin is purified to homogeneity, binding studies in solution will be required to confirm this result, while establishing the affinity and stoichiometry of this interaction.
Neither amelin nor synapsin I bound biotinylated calmodulin; however, the 6 1 kDa subunit of calcineurin, caldesmon (135 kDa), and the 240 kDa subunit of brain spectrin did exhibit biotinylated calmodulin binding (Fig. 3B ).
Amelin and synapsin I are structurally distinct To determine the extent of structural relatedness between amelin and synapsin I, we carried out a comparison of the 2-d& mensional chymotryptic iodopeptide maps of amelin, synapsin I, and erythrocyte protein 4.1 (Fig. 4) . There was little homology (-17% spot overlap) between amelin (Fig. 4B ) and synapsin I (Fig. 4C') . The peptide maps of amelin (Fig. 4B ) and rbc protein 4.1 (Fig. 4A ) demonstrate partial homology (-50% spot overlap), while a comparison of the map of synapsin I with that of rbc protein 4.1 reveals fewer common spots (-33% spot overlap). Therefore, amelin is structurally distinct from synapsin I and appears to be more structurally related to rbc protein 4.1 The gels were stained with Coomassie blue (A), or electrophoretically transferred to nitrocellulose (Towbin et al., 1979) . Biotinylated calmodulin and 1*51-brain spectrin overlay of 2-dimensional gel transfers. Total brain proteins were electrophoresed in a pH 6-10.5 NEPHGE gel, followed by electrophoresis in a 7% SDS-polyacrylamide gel using the Laemmli buffer system in the second dimension. The proteins were transferred to nitrocellulose and reacted with amido black, biotinylated calmodulin, or lZ51-brain spectrin. A, Amido black staining of proteins. *, Amelin, 0, synapsin I. B, Biotinylated calmodulin overlay visualized with alkaline phosphotase. The calmodulin-binding proteins brain spectrin (240 kDa), calcineurin (135 kDa), and caldesmon (6 1 kDa) are indicated in the reference lane by arrmvs. C, lz51-brain spectrin overlay. *, Amelin, 4, 178 and 159 kDa doublet, 0, synapsin I. D, Heat-denatured lz51-brain spectrin control overlay.
than synapsin I. A more complete analysis of structural similarities between amelin, synapsin I, and rbc protein 4.1 will require sequence analysis.
Discussion apsin I. Amelin is a basic protein with a molecular weight of -93 kDa. The antibody against rbc protein 4.1 cross-reacts with this immunoreactive brain analog, which is localized to the cell body and dendrites of neurons and to the soma of certain glial cells. Amelin, like synapsin I, is capable of binding 122-brain In this study we have demonstrated that the brain protein 4.1 analog originally described by Goodman et al. (1984a) , and now termed amelin, is distinct in structure and location from synspectrin, while neither amelin nor synapsin I appears to be a calmodulin-binding protein. ping, their common epitopes, recognized by rbc 4.1 antibody, and the ability of amelin to bind brain spectrin in blot binding assays justifies amelin's inclusion as a 4.1-related protein. Indeed, amelin appears to be more structurally related to rbc protein 4.1 than does synapsin I. The isolation of amelin will be required to determine the stoichiometry and affinity of amelin binding to brain spectrin, and its ability to stimulate the brain spectrin-actin interaction. Synapsin I is more basic than amelin, and is composed of sequence-related polypeptides of 76 and 70 kDa. We see only weak cross-reactivity between our rbc protein 4.1 antibody and synapsin I. In separate studies, we have demonstrated a difference of 3 orders of magnitude between the ability of this antibody to detect rbc protein 4.1 and its ability to detect synapsin I in competitive quantitative dot assays (Krebs et al., 1986~) . We chose this antibody for these studies because it was the original antibody used to define brain protein 4.1 (Goodman et al., 1984a) , and its very weak cross-reactivity with synapsin I allowed us to compare and contrast the immunohistochemical localization of amelin and synapsin I. Two other polyclonal antibodies against rbc 4.1 in our laboratory (one against human rbc 4.1 and another against pig rbc 4.1) cross-react with amelin, and only weakly, if at all, with synapsin I (K. E. Krebs and S. R. Goodman, unpublished observations) . The extent of crossreactivity between rbc 4.1 antibody and synapsin I reported by others (Baines and Bennett, 1985) is difficult to assess, owing to the possibility of differences in antisera specificity, and to the fact that the exposure times of immunoautoradiographs were not presented. Synapsin I also demonstrates little obvious structural homology to rbc protein 4.1, as analyzed by 2-dimensional peptide mapping. Rat brain synapsin Ib and human erythrocyte protein 4.1 cDNA have recently been cloned and sequenced, and the lack of substantial sequence homology confirms our conclusions from peptide mapping (Conboy et al., 1986; McCaffery and DeGennaro, 1986) . The amino acid sequences aligned from their N-termini reveal just 5% identical amino acids and only 19% homology if conservative substitutions of amino acids are made (Steiner et al., 1987) . Therefore, one would predict from the sequences that polyclonal antibodies against rbc protein 4.1 would react weakly or not at all with synapsin I, depending on whether any epitopes resided in the small regions of common sequence. Except for the antibody described by Baines and Bennett (1985) , all other antibodies against rbc 4.1 have been reported to cross-react very weakly or not at all with synapsin I Kanda et al., 1986; Krebs et al., 1987) . Despite these differences, synapsin I has strong functional similarities to rbc protein 4.1.
Synapsin I binds to the O( and fi subunits of brain spectrin immobilized on nitrocellulose paper in a manner similar to the binding of rbc protein 4.1 to rbc spectrin (Baines and Bennett, 1985) . The spectrin binding in Figure 3Cindicates that synapsin Ia may bind brain spectrin with higher affinity than does synapsin Ib, suggesting that the spectrin-binding site may be at an end of synapsin Ia. If this result can be confirmed by other approaches, it has important implications. Recently, McCaffery and DeGennaro (1986) reported that the sequence of rat brain synapsin Ib reveals no homology with a 67 amino acid peptide of human erythrocyte protein 4.1 suggested to be involved in promoting spectrin-actin interactions (Correas et al., 1986) . On the basis of their sequence data, McCaffery and DeGennaro (1986) proposed that synapsin Ia differs from synapsin Ib only at its C-terminal end, the difference being -40 additional amino acids. If synapsin Ia can bind brain spectrin, while synapsin Ib binds brain spectrin only weakly, it is possible that the binding site resides within these 40 amino acids at the C-terminal end of synapsin Ia. This would explain why a sequence related to the spectrin-binding domain of erythrocyte protein 4.1 was not found in the total sequence of synapsin Ib.
Recently, we demonstrated that dephospho-synapsin I binds to spectrin in solution with a Kd and stoichiometry that are nearly identical to those of the binding of rbc protein 4.1 to rbc spectrin (Tyler et al., 1980; Krebs et al., 1987) . In addition, rotary shadowing and electron microscopy of the brain spectrinsynapsin I complex has indicated that synapsin I binds to the terminal ends of the brain spectrin tetramer, analogous to the binding of rbc 4.1 to the rbc spectrin tetramer (Krebs et al., 1985; Krebs et al., 1987) . Finally, synapsin I can stimulate the binding of brain spectrin(240/235) to F-actin (Krebs et al., 1986a, b) , a function that is identical to the essential function of rbc protein 4.1 (Goodman et al., 1984b) . The close functional relationship between synapsin I and rbc protein 4.1 justifies identifying synapsin I as a 4.1-related protein. Synapsin I has been localized to the presynaptic terminals of neurons (DeCamilli et al., 1983 ) and our study is in accord with that location. Recently, neuronal cell body dendritic, axonal, and presynaptic terminal staining of adult rat cerebellum has been observed using antibody against synapsin I (Goldenring et al., 1986) . It is not clear whether this result represents staining of both amelin and synapsin I or, altematively, a more widespread distribution of synapsin I throughout the neuron.
The findings in this study fit well with the recent discovery of 2 distinct spectrin isoforms in mammalian brain . Brain spectrin(240/235) is not recognized by rbc spectrin antibodies and is localized to neuronal axons and presynaptic terminals. Brain spectrin(240/235E) is antigenically related to rbc spectrin and is found in neuronal cell bodies and dendrites, as well as in glial soma. It is possible that synapsin I stimulates the binding of brain spectrin(240/235) to F-actin in the presynaptic terminal, holding synaptic vesicles in place until the appropriate signal. A recent immunoelectron-microscopic study has clearly demonstrated the association of brain spectrin(240/235) with synaptic vesicles in situ .
Amelin, on the other hand may stimulate the binding of brain spectrin(240/235E) to F-actin in the neuronal cell body and dendrites, as well as link brain spectrin(240/235E) to the cytoplasmic surface of the plasma membrane and organelle membranes . By analogy to the erythrocyte, such an association may be essential to the neuronal membrane's structural integrity.
